13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 86 holding rows worth $2,703,471,368.
- Accession
- 0001420506-26-001823
- Filer
- CIK 1920938
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 86 entries on the cover page, a total value of $2,703,471,368 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,703,471,368 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CARIS LIFE SCIENCES INC | 142152107 | COMMON STOCK | 8,256,032 | $147,122,490 | dollars as filed | |
| HINGE HEALTH INC A | 433313103 | COMMON STOCK | 1,330,127 | $110,400,541 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 591,927 | $82,727,718 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,996,965 | $81,136,688 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 879,467 | $78,079,080 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 654,262 | $77,824,465 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 4,918,202 | $71,756,567 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,787,318 | $69,633,909 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,131,452 | $68,294,443 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081GAD4 | NOTE 0.750% 3/1 | 69,121,000 | $66,183,358 | dollars as filed | principal |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 2,451,562 | $59,327,800 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 594,562 | $57,957,904 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 336,171 | $56,656,579 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 6,531,439 | $56,496,947 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 3,283,844 | $55,398,448 | dollars as filed | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 8,702,921 | $54,306,227 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 128,975 | $47,936,138 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 114,500 | $45,481,690 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 89,395 | $44,819,077 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 378,163 | $43,363,951 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 381,128 | $42,316,642 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 1,620,377 | $42,146,006 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,646,399 | $41,653,895 | dollars as filed | |
| BRIGHTSPRING HEALTH SVCS | 10950A106 | COM | 596,753 | $41,617,554 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 609,715 | $40,497,270 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 710,880 | $39,240,576 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 2,797,375 | $36,477,770 | dollars as filed | |
| CAREDX INC | 14167L103 | COM | 1,220,602 | $34,787,157 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,140,040 | $34,018,794 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 483,822 | $33,964,304 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 1,141,477 | $33,707,816 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 473,617 | $33,063,203 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 2,126,298 | $31,766,892 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,286,769 | $31,217,016 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 677,570 | $30,226,398 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 1,629,182 | $30,107,283 | dollars as filed | |
| ALAMAR BIOSCIENCES INC | 010911105 | COMMON STOCK | 1,083,983 | $29,365,099 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 150,627 | $28,691,431 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 70,137 | $27,892,082 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 278,164 | $26,472,868 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 801,395 | $26,381,923 | dollars as filed | |
| AVEANNA HEALTHCARE HLDGS INC | 05356F105 | COM | 3,065,106 | $26,267,958 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 1,033,129 | $25,321,992 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 587,567 | $25,077,360 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 564,724 | $24,232,307 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 177,100 | $24,163,524 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 3,980,295 | $23,483,741 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 147,850 | $22,181,936 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 3,155,209 | $21,897,150 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 79,500 | $21,580,275 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 1,100,370 | $21,050,078 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 53,960 | $20,867,951 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 596,900 | $20,518,438 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 921,598 | $20,468,692 | dollars as filed | |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 18,011,000 | $16,885,250 | dollars as filed | principal |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 521,327 | $16,552,132 | dollars as filed | |
| REPLIGEN CORP | 759916AD1 | NOTE 1.000%12/1 | 16,000,000 | $16,445,954 | dollars as filed | principal |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 17,707 | $16,428,023 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 436,646 | $16,247,598 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 5,919,464 | $15,923,358 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 3,458,429 | $14,732,908 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 301,652 | $13,894,091 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 2,922,754 | $13,649,261 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,214,540 | $13,153,468 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 183,822 | $11,755,417 | dollars as filed | |
| OCULIS HOLDING AG | H5870P102 | CMN | 834,183 | $11,570,118 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,142,348 | $11,333,021 | dollars as filed | |
| SEAPORT THERAPEUTICS INC | 81221K108 | COMMON STOCK | 500,000 | $10,860,000 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 573,104 | $10,550,845 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 390,753 | $10,140,040 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 645,010 | $9,913,804 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 900,000 | $9,540,000 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 116,762 | $9,258,059 | dollars as filed | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 43,200 | $9,156,240 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 795,214 | $9,144,961 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 584,412 | $8,503,195 | dollars as filed | |
| KARDIGAN INC | 485925101 | CMN | 300,000 | $7,155,000 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 700,000 | $7,112,000 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 160,000 | $5,876,800 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 207,240 | $5,570,611 | dollars as filed | |
| WATERS CORP COM | 941848103 | Stock | 14,040 | $5,265,562 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 400,000 | $4,280,000 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 250,000 | $2,840,000 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 752,541 | $978,303 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 916,077 | $596,091 | dollars as filed | |
| Cyclerion Therapeutics Inc | 23255M204 | COM | 156,890 | $531,857 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-001823 | this filing | 2026-08-14 | acceptance time not in the bulk data set |